Explore the latest insights, updates, and breakthroughs in cryopreservation and Pentahibe innovation.
Is it time to move beyond DMSO?Discover how Pharmacosmos is shaping the future of safe, efficient cryopreservation with Pentahibe — a next-gen, biocompatible solution for cells, tissues, and organoids.
Can organoid success start with cryopreservation?Discover how Pentahibe Complete enabled 100% organoid establishment from preserved biopsies, in collaboration with the Cambridge Stem Cell Institute.
Pharmacosmos and InVitria introduce an animal-origin-free cryopreservation strategy for T cells, combining Pentahibe® Base and Optibumin® 25 to deliver strong results with just 2% DMSO.
Research shows that reducing DMSO from 10% to 5% dramatically lowers infusion-related adverse events—without affecting engraftment. At Pentahibe, this is our mission: safe and efficient cryopreservation with no compromise.
Visit our Data & Documents page to learn more.